SMILES string
O1[C@@H]([C@@H]([C@H](C1OCC)O)OCc4ccccc4)C(OCc3ccccc3)COCc2ccccc2
InChI key
ULLNJSBQMBKOJH-NUZMXOBKSA-N
InChI
1S/C29H34O6/c1-2-32-29-26(30)28(34-20-24-16-10-5-11-17-24)27(35-29)25(33-19-23-14-8-4-9-15-23)21-31-18-22-12-6-3-7-13-22/h3-17,25-30H,2,18-21H2,1H3/t25?,26-,27-,28-,29?/m1/s1
grade
pharmaceutical primary standard
API family
tribenoside
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
shipped in
wet ice
storage temp.
−20°C
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Tribenoside EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
Packaging
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
Other Notes
Sales restrictions may apply.
存储类别
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
涉药品监管产品
此项目有
A Sioufi et al.
European journal of drug metabolism and pharmacokinetics, 7(3), 223-228 (1982-01-01)
In an experiment on three healthy volunteers, plasma levels of tribenoside and the elimination of benzoic acid in plasma and urine were followed up during a 7-day period of daily oral medication with tribenoside. Plasma levels of tribenoside, and plasma
Glyvenol therapy in varicose veins an evaluation of its effectiveness.
I Kakande
East African medical journal, 58(7), 532-538 (1981-07-01)
[Clinical experiences with a vasoprotective drug in the treatment of venous problems of the lower limbs].
M De Caprio et al.
La Clinica terapeutica, 101(5), 497-508 (1982-06-15)
M Horváth et al.
Allergologia et immunopathologia, 10(1), 25-32 (1982-01-01)
The in vitro effects of azathioprine, clofibrate and tribenoside on the cell-mediated immune response was studied in some vascular diseases. Imuran decreased leucocyte migration inhibition induced by vascular antigens in patients with myocardial infarction, peripheral arterial disease or superficial thrombophlebitis.
[Treatment of retinal vein thrombosis (author's transl)].
B Hermel et al.
Klinika oczna, 83(7-8), 395-396 (1981-07-01)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持